Package | Dosage | Price | Price per Dose | |
---|---|---|---|---|
Dosage: 1,5mg | ||||
360 pill | 1,5mg | NZD526.57 | NZD1.46 | |
240 pill | 1,5mg | NZD358.40 | NZD1.49 | |
180 pill | 1,5mg | NZD275.17 | NZD1.53 | |
120 pill | 1,5mg | NZD193.63 | NZD1.61 | |
90 pill | 1,5mg | NZD151.16 | NZD1.68 | |
60 pill | 1,5mg | NZD101.90 | NZD1.70 | |
30 pill | 1,5mg | NZD54.34 | NZD1.80 | |
Dosage: 3mg | ||||
360 pill | 3mg | NZD482.41 | NZD1.34 | |
240 pill | 3mg | NZD338.02 | NZD1.41 | |
180 pill | 3mg | NZD263.28 | NZD1.46 | |
120 pill | 3mg | NZD190.23 | NZD1.58 | |
90 pill | 3mg | NZD151.16 | NZD1.68 | |
60 pill | 3mg | NZD110.40 | NZD1.83 | |
30 pill | 3mg | NZD62.83 | NZD2.09 |

Rivastigmine Tartrate Description
Introduction to Rivastigmine Tartrate
Rivastigmine Tartrate is a medication commonly prescribed to treat cognitive symptoms associated with Alzheimer's disease and Parkinson's disease dementia. It belongs to a class of drugs known as cholinesterase inhibitors, which work by increasing the amount of acetylcholine in the brain. Acetylcholine is a neurotransmitter essential for learning and memory. As these neurodegenerative conditions progress, acetylcholine levels decline, leading to memory loss and other cognitive impairments. Rivastigmine aims to mitigate these symptoms and improve quality of life.
How Rivastigmine Tartrate Works
This medication inhibits the enzyme cholinesterase, responsible for breaking down acetylcholine. By blocking this enzyme, Rivastigmine helps to maintain higher levels of acetylcholine in the brain. This mechanism can enhance communication between nerve cells and temporarily improve cognitive functions. Unlike some other treatments, Rivastigmine is available in both oral and transdermal patch forms, providing flexibility in administration based on patient needs and preferences.
Usage and Dosage
Rivastigmine is typically prescribed in starting doses that are gradually increased to minimize side effects. The initial dose may be as low as 1.5 mg twice daily for oral tablets or a low-strength patch. Over time, the dose can be adjusted based on the patient's response and tolerability, up to a maximum recommended dose. It is important to follow the healthcare provider's instructions precisely and not to alter the dosage independently. The medication should be taken with food to reduce gastrointestinal discomfort.
Potential Benefits of Rivastigmine Tartrate
Many patients experience a slowing of cognitive decline and improved daily functioning while on Rivastigmine. It can help with memory, attention, and reasoning, making everyday activities easier to manage. The transdermal patch form offers the added benefit of a steady medication release, which may lessen gastrointestinal side effects often associated with oral formulations. Consistent treatment may also help reduce behavioral symptoms linked to dementia, such as agitation or mood swings.
Possible Side Effects and Risks
Like all medications, Rivastigmine Tartrate can cause side effects. Common issues include nausea, vomiting, diarrhea, dizziness, and weight loss. Some patients may also experience skin irritation at the site of the patch application. In rare cases, more serious side effects such as heart problems or severe allergic reactions can occur. It is vital to monitor for adverse effects and communicate with a healthcare professional if any unusual symptoms develop. Regular medical check-ups are necessary to ensure the medication's safety and effectiveness.
Precautions and Interactions
Before starting Rivastigmine, patients should inform their doctor of any existing health conditions and medications. It may interact with other drugs that influence the central nervous system, such as anticholinergic agents, which can reduce its effectiveness. Caution is advised for patients with a history of heart problems, gastrointestinal issues, or Parkinson's disease. Pregnant or breastfeeding women should discuss the risks and benefits with their healthcare provider, as there is limited information on safety in these populations.
Conclusion
Rivastigmine Tartrate remains a valuable option in managing symptoms of dementia related to Alzheimer’s and Parkinson’s diseases. Its dual administration forms offer convenience and tailored treatment approaches. While it can provide significant cognitive benefits, careful management and monitoring are essential to minimize side effects and maximize therapeutic outcomes. Consistent adherence to medical guidance helps ensure that patients gain the full benefits of this medication, supporting better daily functioning and overall well-being.